TAVI术后心脏康复参与率及结局:新冠前后全人群研究
康复参与率在首次新冠封锁期间下降、疫情后回升;校正后康复与较低的全因再住院和非心血管再住院风险相关,但与心衰再住院和死亡无关。
要点
- TAVI术后心脏康复参与率极低,仅4.4%。
- 康复与全因再住院(HR 0.88)和非心血管再住院(HR 0.84)风险降低相关。
- 康复与心衰再住院及死亡风险无显著关联。
核心结论
- TAVI术后心脏康复参与率在首次新冠封锁期间下降但疫情后快速回升。
- 心脏康复与较低的全因再住院和非心血管再住院风险相关。
- 心脏康复与心衰再住院或死亡风险降低无显著关联。
研究设计与样本
- 回顾性全人群队列研究,使用英格兰电子健康记录。
- 随访最长5年,最短12个月,多变量模型校正人口学、临床因素和操作并发症。
主要发现
- 心脏康复参与率在首次新冠封锁期间降至每万人日1.57,疫情后恢复至3.24。
- 心衰再住院率在康复组与非康复组相似(每万人日1.05 vs 1.02)。
- 全因再住院率(4.49 vs 4.72)、非心血管再住院率(4.53 vs 4.82)和死亡率(3.61 vs 3.84)在康复组略低。
- 校正后心脏康复与全因再住院(HR 0.88,95%CI 0.79-0.98;p=0.019)和非心血管再住院(HR 0.84,95%CI 0.76-0.94;p=0.002)风险降低相关。
临床怎么用
- TAVI术后应重视心脏康复的转介与参与,尤其关注疫情等特殊时期康复服务的连续性。
- 心脏康复可能有助于减少全因和非心血管再住院,但对心衰再住院和死亡的影响需进一步研究确认。
局限性
- 为回顾性观察性研究,存在残留混杂可能。
- 心脏康复参与率极低(4.4%),可能影响结果的外推性。
- 作者指出需要更多研究确认这些临床发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence on cardiac rehabilitation (CR) after transcatheter aortic valve implantation (TAVI) is limited. We examined CR participation across England before, during and after the COVID-19 pandemic, and its association with clinical outcomes. METHODS: This retrospective cohort study used whole-population electronic health records to evaluate characteristics and outcomes of all TAVI recipients in England (2018-2023), stratified by CR participation. The primary outcome was unplanned all-cause rehospitalisation. Secondary outcomes included all-cause mortality, heart failure (HF) rehospitalisation and non-cardiovascular rehospitalisation. Follow-up was up to 5 years, with a minimum of 12 months. Multivariable models adjusted for demographics, clinical factors and procedural complications. RESULTS: Among 24 925 TAVI recipients (56% male, mean age 81 years and 95% white ethnicity), only 1090 (4.4%) attended CR. CR rates dropped during the first COVID-19 lockdown (1.57 per 10 000 person-days) and recovered post pandemic (3.24). HF rehospitalisation rates per 10 000 person-days were similar between CR and non-CR groups (1.05 vs 1.02), while all-cause (4.49 vs 4.72), non-cardiovascular rehospitalisation (4.53 vs 4.82) and mortality rates (3.61 vs 3.84) were slightly lower among CR participants. After adjustment, CR was associated with lower risk of all-cause (HR 0.88, 95% CI 0.79 to 0.98; p=0.019) and non-cardiovascular rehospitalisation (HR 0.84, 95% CI 0.76 to 0.94; p=0.002); however, there was no evidence of an association between CR and HF rehospitalisation (HR 0.94, 95% CI 0.75 to 1.19; p=0.607) or mortality (HR 0.95, 95% CI 0.84 to 1.07; p=0.383). CONCLUSION: CR after TAVI declined during the first COVID-19 lockdown but rebounded quickly. CR was associated with lower all-cause and non-cardiovascular rehospitalisation but was not associated with lower HF rehospitalisation or mortality. More research is needed to confirm these clinical findings.
引用
- Braver J, Marwick TH, Nolan J, et al. Cardiac rehabilitation after transcatheter aortic valve implantation before, during and after the COVID-19 pandemic: a whole-population study. Heart. 2026. PMID: 41932822. doi:10.1136/heartjnl-2025-327186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。